Literature DB >> 25896231

Deletion of UNC5B in Kidney Epithelium Exacerbates Diabetic Nephropathy in Mice.

Punithavathi Ranganathan1, Riyaz Mohamed, Calpurnia Jayakumar, Michael W Brands, Ganesan Ramesh.   

Abstract

BACKGROUND: Guidance cue netrin-1 was shown to have protective effects in diabetic nephropathy. However, the role of its receptor UNC5B in diabetic kidney disease is unknown. Moreover, whether netrin-1 is protective against diabetic kidney disease in a genetic model of nephropathy and in the nephropathy prone DBA background is also unknown. The aim of this study was to determine the significance of UNC5B in tubular epithelial cells in chronic kidney disease due to diabetes and evaluate whether netrin-1 is also protective in the case of a nephropathy-prone mouse.
METHODS: Proximal tubular epithelium-specific UNC5B knockout mice as well as heterozygous UNC5B knockout mice were used to determine the roles of UNC5B in nephropathy. Diabetes was induced in these tissue-specific knockout, heterozygous and WT mice, and albuminuria was then monitored.
RESULTS: WT and heterozygous diabetic mice developed significant albuminuria at 8 weeks after induction of diabetes as compared to buffer-treated control mice. However, albuminuria was significantly more pronounced in mice with proximal tubule specific deletion of UNC5B. Transgenic overexpression of netrin-1 in proximal tubules in the DBA background and administration of recombinant netrin-1 to Ins2Akita mice also significantly reduced diabetes-induced albuminuria and suppressed glomerular and interstitial lesions.
CONCLUSION: Our data suggested that netrin-1 signaling in proximal tubular epithelium may play a critical role in the protection of kidney against diabetic kidney disease.
© 2015 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25896231      PMCID: PMC4441848          DOI: 10.1159/000381428

Source DB:  PubMed          Journal:  Am J Nephrol        ISSN: 0250-8095            Impact factor:   3.754


  27 in total

1.  Netrins promote developmental and therapeutic angiogenesis.

Authors:  Brent D Wilson; Masaaki Ii; Kye Won Park; Arminda Suli; Lise K Sorensen; Fréderic Larrieu-Lahargue; Lisa D Urness; Wonhee Suh; Jun Asai; Gerhardus A H Kock; Tina Thorne; Marcy Silver; Kirk R Thomas; Chi-Bin Chien; Douglas W Losordo; Dean Y Li
Journal:  Science       Date:  2006-06-29       Impact factor: 47.728

Review 2.  The Netrin family of guidance factors: emphasis on Netrin-1 signalling.

Authors:  María J Barallobre; Marta Pascual; José A Del Río; Eduardo Soriano
Journal:  Brain Res Brain Res Rev       Date:  2005-01-15

Review 3.  Mouse models of diabetic nephropathy.

Authors:  Matthew D Breyer; Erwin Böttinger; Frank C Brosius; Thomas M Coffman; Raymond C Harris; Charles W Heilig; Kumar Sharma
Journal:  J Am Soc Nephrol       Date:  2004-11-24       Impact factor: 10.121

4.  Netrin-1 overexpression protects kidney from ischemia reperfusion injury by suppressing apoptosis.

Authors:  Weiwei Wang; William Brian Reeves; Laurent Pays; Patrick Mehlen; Ganesan Ramesh
Journal:  Am J Pathol       Date:  2009-08-21       Impact factor: 4.307

5.  Netrin-1 and kidney injury. I. Netrin-1 protects against ischemia-reperfusion injury of the kidney.

Authors:  Weiwei Wang; W Brian Reeves; Ganesan Ramesh
Journal:  Am J Physiol Renal Physiol       Date:  2008-01-23

6.  Segment-specific expression of netrin-1 receptors in normal and ischemic mouse kidney.

Authors:  Weiwei Wang; Ganesan Ramesh
Journal:  Am J Nephrol       Date:  2009-02-04       Impact factor: 3.754

Review 7.  Pathogenic perspectives for the role of inflammation in diabetic nephropathy.

Authors:  Antonio Rivero; Carmen Mora; Mercedes Muros; Javier García; Havidian Herrera; Juan F Navarro-González
Journal:  Clin Sci (Lond)       Date:  2009-03       Impact factor: 6.124

8.  Hypoxia-inducible factor-dependent induction of netrin-1 dampens inflammation caused by hypoxia.

Authors:  Peter Rosenberger; Jan M Schwab; Valbona Mirakaj; Eva Masekowsky; Alice Mager; Julio C Morote-Garcia; Klaus Unertl; Holger K Eltzschig
Journal:  Nat Immunol       Date:  2009-01-04       Impact factor: 25.606

9.  The netrin receptor UNC5B promotes angiogenesis in specific vascular beds.

Authors:  Sutip Navankasattusas; Kevin J Whitehead; Arminda Suli; Lise K Sorensen; Amy H Lim; Jia Zhao; Kye Won Park; Joshua D Wythe; Kirk R Thomas; Chi-Bin Chien; Dean Y Li
Journal:  Development       Date:  2008-02       Impact factor: 6.868

Review 10.  The role of inflammatory cytokines in diabetic nephropathy.

Authors:  Juan F Navarro-González; Carmen Mora-Fernández
Journal:  J Am Soc Nephrol       Date:  2008-02-06       Impact factor: 10.121

View more
  5 in total

1.  Specific MAPK inhibitors prevent hyperglycemia-induced renal diseases in type 1 diabetic mouse model.

Authors:  Zhe Hong; Zongyuan Hong; Denglong Wu; Hezhongrong Nie
Journal:  Mol Cell Biochem       Date:  2016-07-07       Impact factor: 3.396

Review 2.  Acute Kidney Injury and Progression of Diabetic Kidney Disease.

Authors:  Samuel Mon-Wei Yu; Joseph V Bonventre
Journal:  Adv Chronic Kidney Dis       Date:  2018-03       Impact factor: 3.620

Review 3.  Netrin as a Novel Biomarker and Its Therapeutic Implications in Diabetes Mellitus and Diabetes-Associated Complications.

Authors:  Ebrahim M Yimer; Kaleab Alemayehu Zewdie; Hailemichael Zeru Hishe
Journal:  J Diabetes Res       Date:  2018-09-18       Impact factor: 4.011

4.  Netrin-1 is a novel regulator of vascular endothelial function in diabetes.

Authors:  Haroldo A Toque; Aracely Fernandez-Flores; Riyaz Mohamed; Ruth B Caldwell; Ganesan Ramesh; R William Caldwell
Journal:  PLoS One       Date:  2017-10-23       Impact factor: 3.240

5.  Cellular Recruitment by Podocyte-Derived Pro-migratory Factors in Assembly of the Human Renal Filter.

Authors:  Albert D Kim; Blue B Lake; Song Chen; Yan Wu; Jinjin Guo; Riana K Parvez; Tracy Tran; Matthew E Thornton; Brendan Grubbs; Jill A McMahon; Kun Zhang; Andrew P McMahon
Journal:  iScience       Date:  2019-09-26
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.